12th Annual NC Research Triangle Pulmonary Hypertension Symposium
Learning Objectives
Describe classification of Pulmonary Hypertension, according to the World Symposium classifications and including updates from the 6th World Symposium as well as the treatment options with respect to PAH-specific therapies
Recognize and distinguish similar disease processes that may or may not respond to Pulmonary Arterial Hypertensions specific therapy
Understand diagnostics used in the evaluation of pulmonary hypertension, including echocardiography, CT scan, VQ scan, and right heart catherterization hemodynamic profiles
Identify various PH subtypes and understand their diagnosis and clinical course, particularly chronic thromboembolic pulmonary hypertension and pulmonary hypertension associated with lung disease
Identify the role of clinical trials in the development of new PAH therapies, with a particular appreciation of the patient perspective as a clinical trial subject
Available Credit
- 4.00 ACPE - Pharmacist
- 4.00 AMA PRA Category 1 Credit(s)™
- 4.00 ANCC
- 4.00 Attendance
- 4.00 JA Credit - AH
- 4.00 Approved for AMA PRA Category 1 Credit(s)™